Scheduling assistant for independent physiotherapy clinics

Missed and late-cancelled appointments are a direct, measurable revenue loss for a small clinic, and the current workaround is a person making phone calls between patients. That makes this an easier sale than most software: the buyer already knows what the problem costs them. The risk is not demand, it is defensibility - reminders are a feature an incumbent could bundle. The recommendation is to build the narrow version quickly and win on setup time rather than feature count.

• •Target is single-location physiotherapy practices.
• •Appointments are currently coordinated by phone.
• •Founder is technical and building solo.
• •Target market is the United States and European Union.

A no-show is not an inconvenience, it is an unsold hour that cannot be recovered - unlike retail stock, clinic capacity expires. Practices already spend staff time on reminder calls, which means the problem is being paid for today, just inefficiently. That is the strongest signal available short of a paid pilot: a workaround exists and has a cost attached to it.

The base is large and highly fragmented: independent practices are numerous, individually small, and poorly served by practice-management suites priced and scoped for multi-site groups. Fragmentation cuts both ways. It means little competition for the low end, and it means no efficient channel to reach them - acquisition, not demand, is the constraint on growth here.

Segments were ordered by decision speed rather than contract size. A solo founder cannot afford a three-month sales cycle before knowing whether the product retains, so the buyer who can say yes immediately is the right first target even though they pay less.

The realistic competitor is not another product, it is the phone and a paper diary. Above that sit full practice-management suites that include scheduling as one module among billing, notes and insurance - capable, but priced and scoped for practices several times larger. Between the two there is very little.

The defensible position is scope discipline, not features: a tool that solves the no-show problem completely and does nothing else, which a clinic owner can have working before their next patient. That is genuinely hard for an incumbent to copy, because their constraint is not capability but the onboarding weight of everything else they sell. 'Better UX' is not a differentiator and should not be relied on.

Flat per-clinic monthly subscription. Per-seat pricing is the obvious default and the wrong one here: these clinics have two or three people, so per-seat caps revenue at a trivial number while adding a counting conversation to every sale. Price against the value of recovered appointments, not against seats.

The deferred list is what turns this into a practice-management suite, which is the market that is already served. Everything in scope exists to reduce no-shows; anything that does not is a distraction until retention is proven.

Beliefs this analysis rests on. Each one is worth testing before you commit.

1. 1

   Interview fifteen clinic owners about their current no-show rate and what it costs them.

   days

   Signal to look for

   A number given without hesitation. An owner who has to guess has not felt the problem enough to buy.

2. 2

   Attempt to close one paid pilot in a single conversation, before building.

   days

   Signal to look for

   Payment, or a specific objection. A polite 'send me something' is a no.

3. 3

   Price out SMS delivery at realistic per-clinic volumes for both target regions.

   hours

   Signal to look for

   Message cost staying under a tenth of the subscription price at the busiest plausible clinic.